Stay updated with breaking news from Synlogic Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Synlogic (NASDAQ:SYBX – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Friday, Zacks.com reports. According to Zacks, “Synlogic, Inc. engaged in the development of a novel class of living Synthetic Biotic(TM) medicines based on its proprietary drug discovery and […]
Synlogic, Inc. (NASDAQ:SYBX – Get Rating) – SVB Leerink decreased their Q4 2022 earnings per share estimates for shares of Synlogic in a report released on Tuesday, May 17th. SVB Leerink analyst J. Schwartz now expects that the biotechnology company will post earnings per share of ($0.24) for the quarter, down from their previous estimate […]
Investment Analysts’ downgrades for Friday, May 20th: Asbury Automotive Group (NYSE:ABG) was downgraded by analysts at Morgan Stanley from an equal weight rating to an underweight rating. American Equity Investment Life (NYSE:AEL) was downgraded by analysts at StockNews.com from a buy rating to a hold rating. Allstate (NYSE:ALL) was downgraded by analysts at Argus from […]
Synlogic (NASDAQ:SYBX – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Thursday, Zacks.com reports. The firm currently has a $1.25 price target on the biotechnology company’s stock. Zacks Investment Research‘s target price points to a potential upside of 13.64% from the […]
Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pha...